Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Whengeorgiasmiles Com Robin Mcgraw"

19:57 EDT 24th April 2014 | BioPortfolio

Matching Channels

None

Matching News

CereScan partners with Tug McGraw Foundation to improve brain injury treatment

CereScan (Denver) is partnering with the Tug McGraw Foundation to seek new and more efficient identification of and treatment for invisible wounds such as Mild Traumatic Brain Injury (mTBI). http://i...

India Commerce Chief Vows No 'Robin Hood' Use Of Compulsory License"

India's commerce secretary vowed in an interview that the compulsory license tool in drug regulation would not be used as a Robin Hood-style way of taking from the rich to give to the poor.

CEO Dr. Robin Smith of NeoStem to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW 1190AM / Today at 1:05pm CST / 2:05 pm EST on The Traders Network With Host Michael Yorba

NEW YORK, NY -- (Marketwired) -- 02/12/14 -- NeoStem, Inc. (NASDAQ: NBS) ("NeoStem"), a leader in the emerging cellular therapy industry, today announced that Chairman and CEO Dr. Robin L. Smith wi...

Robin J. Hoover, RN, BSN, Represents Kentucky with Entry into Renowned Publication Worldwide Leaders in Healthcare

Worldwide Leaders in Healthcare and the International Nurses Association are proud to announce that Robin J. Hoover, RN, BSN, is being honored for her exceptional successes in the nursing community. W...

Robin Hood releases Poverty Tracker survey results

Today, Robin Hood announced the release of the Poverty Tracker survey results, developed in partnership with Columbia University's Population Research Center. This quarterly survey of 2,300 households...

NeoStem CEO Dr. Robin L. Smith to Be Interviewed Live on Clear Channel Network's Business Radio DFW 1190AM / Interview to Air December 5 on Clear Channel's "The Traders Network" Talk Radio Show Hosted by Michael Yorba

NEW YORK, NY -- (Marketwired) -- 12/04/13 -- NeoStem, Inc. (NASDAQ: NBS) ("NeoStem") a leader in the emerging cellular therapy industry, today announced that Dr. Robin L. Smith, Chairman and CEO, w...

NeoStem CEO Dr. Robin Smith's Interview on Clear Channel Business Talk Radio Recap

NeoStem, Inc. (NASDAQ: NBS) ("NeoStem"), a leader in the emerging cellular therapy industry, today announced that Dr. Robin L. Smith, Chairman and CEO, was interviewed live on Clear Channel's "the Tra...

CEO Dr. Robin Smith of NeoStem to Discuss Agreement to Acquire California Stem Cell, Inc. Live Today on Clear Channel's "The Traders Network Show" / Interview Airs at 2:30pm EDT / 1:30pm CDT / 11:30am PDT on the Traders Network Radio Show, Hosted by Mich

NEW YORK, NY -- (Marketwired) -- 04/15/14 -- NeoStem, Inc. (NASDAQ: NBS) ("NeoStem"), a leader in the emerging cellular therapy industry, announced today that Chairman and CEO, Dr. Robin Smith, wi...

Matching PubMed Articles

Birth prevalence and initial treatment of Robin sequence in Germany: a prospective epidemiologic study.

We conducted a monthly epidemiological survey to determine the birth prevalence of Robin sequence (RS) and the use of various therapeutic approaches for it.

Tracheostomy versus mandibular distraction osteogenesis in infants with Robin sequence: a comparative cost analysis.

Many treatments have been described for infants with Robin sequence and severe respiratory distress, but there have not been many comparative studies of outcome and cost-effectiveness. The aim of this...

Robert ('Robin') Hill: An appreciation.

Dr Robin Hill: Natural dyes.

Robin Hill: A personal perspective.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement